About Biocon Our Business Research & Development Biocon's Technology Investors Media Careers CSR
  Press Releases
  Media Stories
  Download Center
  Video Gallery
  Photo Gallery
  Media Contacts

Media Stories

2019 2018 2017 2016 2015

December 2019
11 Dec Biocon, partner Mylan launch oncology biosimilar trastuzumab in US
November 2019
28 Nov USFDA nod to Biocon's new Bengaluru unit
28 Nov Biocon, Mylan get nod for pegfilgrastim drug
October 2019
30 Oct Indian company makes it to top 10 best employers in biotech category
26 Oct Insulin at ₹7 will be a gamechanger for us
25 Oct Biocon sets $1 billion target for biologics business
September 2019
28 Sep Life-enabling productlike insulin should be made affordable: Shaw
27 Sep Biocon plans to halve insulin prices
25 Sep Blueprint for a Healthy India
25 Sep Biocon subsidiary acquires Pfizer’s R&D facility in Chennai
August 2019
22 Aug Ramp-up of biosimilar portfolio to boost Biocon
July 2019
30 Jul Our aim is to be a global leader in biosimilars biz: Biocon Biologics CEO
26 Jul Biocon’s net rises 86%, revenue 25%
25 Jul Biocon net profit grows 72%
June 2019
18 June Biosimilars, research key drivers for Biocon
18 June Trastuzumab’s US launch will be a big opportunity for Biocon-Mylan: Shaw
15 June Biocon’s Bengaluru biologics units get European agency nod
8 June The First Lady of Biotech
May 2019
30 May Biocon, Mylan to present data for Ogivri at ASCO meeting
23 May Canada clears Mylan & Biocon's Biosimilar
20 May Biologics to boost Biocon business, say analyst
9 May Biocon drug gets commercial rights to global markets
April 2019
30 Apr Biosimilars to help Biocon hit $1bn revenue in FY20
27 Apr Biologics, research services the golden goose for Biocon
26 Apr Biocon Q4 net profit up 64% to ₹213.7 crore
18 Apr Kiran Mazumdar-Shaw conferred with honorary doctorate from Deakin University, Australia
12 Apr Violence,EVM glitches, missing names:Rocky start to election
08 Apr Research must be promoted in colleges
05 Apr ET Prime celebrates Women's Excellence in Business & Innovation
05 Apr Breakthrough innovation is taking place but we're not leveraging it
04 Apr Kiran Mazumdar-Shaw conferred with Honorary Doctorate
01 Apr Biocon Biologics India appoints Dr. Christiane Hamacher as CEO
March 2019
29 Mar Biocon chief stresses on gender equality
19 Mar Kiran back as Infy's independent director
18 Mar Govt Should Scale Up Philanthropic Capital
15 Mar Cost of select insulin increases up to 20%
12 Mar Role of Indian women in Science & Technology
11 Mar The growing share of biosimilars revenue is doing wonders for our business
08 Mar Biosimilars offer a huge opportunity for Biocon
07 Mar Future jobs will be different: Shaw
03 Mar Pharma specialist new CEO of Biocon Biologics
02 Mar Hamacher is CEO of Biocon Biologics
February 2019
28 Feb In bid to curb profiteering, govt caps margins of 42 cancer drugs
23 Feb Shortage of women for leadership roles
18 Feb Biocon's revenue up 43%; Net profit up 136%
13 Feb Biocon's Trastuzumab receives approvals in EU
09 Feb Kiran Mazumdar-Shaw elected member of US-based NAE
04 Feb Socio-Economic Issues Focus Area of Budget 2019
02 Feb Budget Quotes
01 Feb Biocon, Mylan announce positive CHMP opinion for Fulphila
January 2019
31 Jan Why Quitting Should Never Be An Option
29 Jan Stock Reccos
28 Jan Biosimilars make Biocon stand apart
25 Jan Biocon Dec quarter net zooms over two-fold to ₹217 Cr
20 Jan Top-ranked Karnataka doubles down on skill development
16 Jan Biocon focus may shift to non-insulins
13 Jan A Briefcase and A Baby
12 Jan Kiran Mazumdar-Shaw gets second term as Infosys' Lead Independent Director
07 Jan For India's healthy billion





Recommended sites Biocon on  
About Us

Investor Relations
Media Relations
Site Map
Contact Us
Our Growth Accelerators
Fact Sheet
Branded Formulations
Research Services
Active Discovery Program

Karnataka Vision Group on BT
Syngene International
Biocon Academy

    Linked In   
  Report adverse event/side effects and product complaints    
  * Disclaimer            © 2018, Biocon. All Rights Reserved